SciSparc Ltd. filed a Form 6-K with the SEC on October 26, 2026, disclosing an inducement offer letter agreement with L.I.A Pure Capital Ltd. to exercise existing warrants at a reduced price, expected to generate approximately $405,728 in gross proceeds.

Key Highlights

  • Inducement agreement dated October 26, 2026: SciSparc entered into an inducement offer letter agreement with L.I.A Pure Capital Ltd. covering existing warrants to purchase up to 405,728 ordinary shares.
  • Reduced exercise price: The holder agreed to exercise the existing warrants for cash at $1.00 per ordinary share, down from the original exercise price of $4.929 per ordinary share.
  • Expected gross proceeds: The company disclosed it expects to receive aggregate gross proceeds of approximately $405,728 from the exercise of the existing warrants.
  • Closing expected October 27, 2026: The closing is expected to occur on or about October 27, 2026, subject to customary closing conditions, according to the filing.
  • Proceeds designated for working capital: The company stated it expects to use net proceeds from the warrant exercise as working capital for general corporate purposes.
  • Shares previously registered: The resale of the underlying ordinary shares was previously registered under a Form F-3 registration statement (File No. 333-293533), declared effective by the SEC on August 31, 2026.

SciSparc Reduces Warrant Exercise Price to Secure Cash from L.I.A Pure Capital

According to the Form 6-K filed with the U.S. Securities and Exchange Commission, SciSparc Ltd. (NASDAQ:SPRC) entered into an inducement offer letter agreement on October 26, 2026, with L.I.A Pure Capital Ltd. The agreement relates to existing warrants originally issued on February 12, 2026, which carried an exercise price of $4.929 per ordinary share. Under the inducement letter, the holder agreed to exercise those warrants for cash at a reduced price of $1.00 per ordinary share.

The warrants covered under the agreement allow for the purchase of up to 405,728 ordinary shares of SciSparc, which carry no par value. The company disclosed it expects to receive aggregate gross proceeds of approximately $405,728 from the transaction. The filing stated that net proceeds are intended to be used as working capital for general corporate purposes. The transaction's closing is expected on or about October 27, 2026, contingent on the satisfaction of customary closing conditions.

The filing noted that the resale of the ordinary shares underlying the existing warrants had been previously registered pursuant to a Form F-3 registration statement (File No. 333-293533), initially filed on February 17, 2026, amended on August 19, 2026, and declared effective by the SEC on August 31, 2026. The filing also contains forward-looking statements, which the company cautioned are subject to risks and uncertainties, and that "the transaction contemplated in this Form 6-K may not close when expected or at all." The Form 6-K was signed by Oz Adler, Chief Executive Officer and Chief Financial Officer.

What Was Disclosed

SciSparc Ltd. disclosed an inducement offer letter with L.I.A Pure Capital Ltd. to exercise warrants covering 405,728 ordinary shares at a reduced price of $1.00 per share, with expected gross proceeds of approximately $405,728 intended for general corporate working capital purposes.